Joint venture between Basildon and Thurrock University Hospitals and Southend University Hospital NHS Foundation Trusts and Integrated Pathology Partnerships
The CMA is investigating the pathology services joint venture between Basildon and Thurrock University Hospitals NHS Foundation Trust, Southend University Hospital NHS Foundation Trust and Integrated Pathology Partnerships Limited.
Statutory timetable
| Phase 1 date | Action |
|---|---|
| 10 September 2014 | Decision published |
| 28 August 2014 | Decision announced |
| 2 July 2014 | Launch of merger inquiry |
Phase 1
CMA clearance decision
28 August 2014: The CMA has cleared the pathology services joint venture between Basildon and Thurrock University Hospitals NHS Foundation Trust, Southend University Hospital NHS Foundation Trust and Integrated Pathology Partnerships Limited. The full text of the decision is available below:
Invitation to comment: Now closed
2 July 2014: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
Launch of OFT merger inquiry
The CMA announced the launch of its merger inquiry by Notice to the parties on 2 July 2014.
Contact
Please send written representations about any competition or public interest to:
Peter Swan
Competition and Markets Authority
Victoria House
37 Southampton Row
London
WC1B 4AD